Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2016 Filed Feb 10, 2017 23:32 UTC |
Hamood Samuel AEVP & CFO
|
GiftCommon Stock | 38,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001645772-17-000002 · wf-form5_148676952774233.xml · nonDerivative · entry 2 Hamood Samuel A · CIK 0001645772 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 99,829 F1 · balance_after: Includes 857 shares of common stock acquired pursuant to the issuer's employee stock purchase plan in 2016, which acquisitions are exempt from Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| February 19, 2016 Filed Feb 10, 2017 23:32 UTC |
Hamood Samuel AEVP & CFO
|
GiftCommon Stock | 38,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001645772-17-000002 · wf-form5_148676952774233.xml · nonDerivative · entry 1 Hamood Samuel A · CIK 0001645772 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.